All News

The drug is made from Ananda’s Liquid Structure technology that creates new potential for cannabidiol therapeutics, such as facilitating voluntary opioid sparing.

Alyson McGregor, MD, of Brown University explains what pharmacists can do to advance issues arising around the impact of sex and gender on medicine.

Xlear treats sinus pressure and congestion caused by colds, flu, allergies, pollen, and post-nasal drip.

Anifrolumab-fnia is a human immunoglobulin G (IgG)1κ monoclonal antibody indicated for the treatment of moderate to severe systemic lupus erythematosus.

Generalized anxiety disorder has symptoms that are similar to panic disorder, obsessive-compulsive disorder, and other types of anxiety.

Abby Sauer, a registered dietitian specializing in adult nutrition at Abbott, discusses how the unique nutritional needs of women evolve with age and some tips pharmacists can provide to women 30 years of age and older in the pharmacy.

The submission is supported by data from MajesTEC-1, a multicenter clinical trial evaluating the safety and efficacy of teclistamab in adults with RRMM.

In laboratory molecular tests, scientists mix samples with assay reagents in a highly controlled process, but because the reaction conditions are tightly controlled, the tests are both sensitive and selective, according to the researchers.

Pay for outcomes is here to stay, but are pharmacy claims an outdated source of quality measurement?

Rebecca Sleeper, PharmD, FCCP, FASCP, BCPS, of the Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy, discusses how a lack of sex and gender specific patient care education can impact a pharmacist’s work with their patients.

In the first quarter of 2022, Genprex expects to initiate its Acclaim-2 clinical trial to evaluate the treatment for individuals with histologically confirmed unresectable stage III or IV non–small cell lung cancer.

Tixagevimab co-packaged with cilgavimab is one of the only 2 antibody therapies issued emergency use authorization by the FDA that showed neutralizing activity against omicron and all other variants of concern.

Agency greenlights secukinumab’s use for pediatric Treatment of enthesitis-related arthritis and Juvenile psoriatic arthritis.

A survey was administered electronically to key kidney care stakeholders in 182 International Society of Nephrology (ISN)-affiliated countries, with 88% responding and 97% answering the survey items related to kidney nutrition care.

The results of an analysis from investigators from Baylor College of Medicine suggest that supplementation with GlyNAC might be beneficial to those who have the virus.

The metabolic protein SIRT3 reduces the pools of amino acids that cells use to make proteins and otherwise fuel their growth.

Alyson McGregor, MD, of Brown University discusses the focus of her research into sex and gender in emergency medicine.

Telisotuzumab vedotin (Teliso-V, AbbVie) is an investigational antibody-drug conjugate that targets c-Met, a receptor tyrosine kinase that is overexpressed in tumors.

Arnicare temporarily relieves muscle pain and relieves stiffness due to minor injuries.

The efficacy of aripiprazole could be mediated through a combination of partial agonist activity at D2 and 5-HT1A receptors and antagonist activity at 5-HT2A receptors.

In patients with gastroparesis, the stomach's motility is slowed down or doesn't work at all, preventing proper emptying.

The COVID-19 pandemic has increased the need for more helping hands in pharmacies, especially with vaccinations, and the opportunities for techs may last.

The approval marks the first small interfering RNA therapy for low-density lipoprotein cholesterol reduction.

Eli Lilly says the drug in combination with TCS also achieved all key secondary endpoints versus the placebo for individuals with AD.

1960-2021

There are key benefits and risks for student pharmacists to consider when approaching an Instagram account for professional pharmacy purposes.

The study analyzed blood samples taken from individuals infected with COVID-19, those who had been vaccinated with a 2-dose schedule and a third booster dose, and those who had reported previous infection from other COVID-19 variants of concern.

This is an update to the 2011 AAN guideline on the treatment of painful diabetic neuropathy, according to a press release.